Search Results - "Hagerty, Sean W."
-
1
ESET/SETDB1 Gene Expression and Histone H3 (K9) Trimethylation in Huntington's Disease
Published in Proceedings of the National Academy of Sciences - PNAS (12-12-2006)“…Chromatin remodeling and transcription regulation are tightly controlled under physiological conditions. It has been suggested that altered chromatin…”
Get full text
Journal Article -
2
Modulation of nucleosome dynamics in Huntington's disease
Published in Human molecular genetics (15-05-2007)“…Transcriptional dysregulation and aberrant chromatin remodeling are central features in the pathology of Huntington's disease (HD). In order to more fully…”
Get full text
Journal Article -
3
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Published in Biochimica et biophysica acta. Molecular basis of disease (01-06-2006)Get full text
Journal Article -
4
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Published in Biochimica et biophysica acta. Molecular basis of disease (01-03-2006)Get full text
Journal Article -
5
Dose ranging and efficacy study of high-dose coenzyme Q 10 formulations in Huntington's disease mice
Published in Biochimica et biophysica acta. Molecular basis of disease (2006)“…There is substantial evidence that a bioenergetic defect may play a role in the pathogenesis of Huntington's Disease (HD). A potential therapy for remediating…”
Get full text
Journal Article -
6
Combination therapy using minocycline and coenzyme Q 10 in R6/2 transgenic Huntington's disease mice
Published in Biochimica et biophysica acta. Molecular basis of disease (2006)“…Huntington's disease (HD) is a fatal neurodegenerative disorder of genetic origin with no known therapeutic intervention that can slow or halt disease…”
Get full text
Journal Article -
7
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Published in Biochimica et biophysica acta (01-06-2006)“…There is substantial evidence that a bioenergetic defect may play a role in the pathogenesis of Huntington's Disease (HD). A potential therapy for remediating…”
Get more information
Journal Article -
8
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Published in Biochimica et biophysica acta (01-03-2006)“…Huntington's disease (HD) is a fatal neurodegenerative disorder of genetic origin with no known therapeutic intervention that can slow or halt disease…”
Get more information
Journal Article